{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:49:34Z","timestamp":1791236974651,"version":"4.1.0"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Heart rate recovery in 1 minute (HRR1) after the end of the 6-minute walk test (6MWT) is a non-invasive method of determining autonomic dysfunction. This parameter remains largely unexplored in pulmonary arterial hypertension (PAH) registries. We aimed to define the cut-off value and accuracy for abnormal HRR1 after the 6MWT and to investigate the association between HRR1 and clinical worsening in patients with PAH. This composite outcome was defined as first occurrence of all-cause death OR hospitalization from any cause OR disease progression characterized by decreased \u2265 15% in six-minute walking distance from baseline AND start of new specific PAH treatment or persistent worsening of World Health Organization functional class (WHO-FC). We performed a prospective cohort study that included 102 consecutive patients with PAH confirmed by right heart catheterization that underwent an 6MWT upon the diagnosis, recruited from September 2004 to April 2020 and followed up until April 2021 or death. The median HRR1 was 18 beats (IQR: 10\u201322), 50 and 52 PAH patients with &lt;18 beats and \u226518 beats, respectively. The best cut-off for HRR1 to discriminate clinical worsening was 17 beats, with area under the curve (AUC) of 0.704 (95%CI: 0.584\u20130.824). The internal validation model by bootstrap showed an AUC of 0.676 (95%CI: 0.566\u20130.786) and the most accurate value was obtained in the seventh year of follow-up (AUC = 0.711; 95%CI: 0.596\u20130.844). Patients with an HRR1 &lt;18 beats at baseline had a median event-free time of 2.17 years (95%CI: 1.82 to 2.52) versus 4.75 years (95%CI: 1.43 to 8.07) from those with \u226518 beats. In conclusion, a HRR1 value of less than 18 beats may be a reliable indicator of poor prognosis in patients with PAH.<\/jats:p>","DOI":"10.1371\/journal.pone.0268839","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T17:30:05Z","timestamp":1653672605000},"page":"e0268839","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Heart rate recovery in 1 minute after the 6-minute walk test predicts adverse outcomes in pulmonary arterial hypertension"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1043-6054","authenticated-orcid":true,"given":"Camila Farnese","family":"Rezende","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3891-875X","authenticated-orcid":true,"given":"Eliane Viana","family":"Mancuzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1779-0443","authenticated-orcid":true,"given":"Ricardo de Amorim","family":"Corr\u00eaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"pone.0268839.ref001","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"46","author":"N Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"issue":"1","key":"pone.0268839.ref002","doi-asserted-by":"crossref","first-page":"1801889","DOI":"10.1183\/13993003.01889-2018","article-title":"Risk stratification and medical therapy of pulmonary arterial hypertension","volume":"53","author":"N Gali\u00e8","year":"2019","journal-title":"Eur Respir J"},{"issue":"2","key":"pone.0268839.ref003","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC\/ERS-Based Risk Assessment Strategies","volume":"156","author":"RL Benza","year":"2019","journal-title":"Chest"},{"issue":"2","key":"pone.0268839.ref004","doi-asserted-by":"crossref","first-page":"1700740","DOI":"10.1183\/13993003.00740-2017","article-title":"Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model","volume":"50","author":"MM Hoeper","year":"2017","journal-title":"Eur Respir J"},{"key":"pone.0268839.ref005","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1183\/09031936.00150414","article-title":"An official systematic review of the European Respiratory Society\/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease","volume":"44","author":"SJ Singh","year":"2014","journal-title":"Eur Respir J"},{"issue":"5","key":"pone.0268839.ref006","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1183\/09031936.04.00111904","article-title":"Exercise testing in pulmonary arterial hypertension and in chronic heart failure","volume":"23","author":"G Deboeck","year":"2004","journal-title":"Eur Respir J"},{"issue":"4","key":"pone.0268839.ref007","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1164\/rccm.201105-0848OC","article-title":"Heart rate recovery predicts clinical worsening in patients with pulmonary arterial hypertension","volume":"185","author":"OA Minai","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"pone.0268839.ref008","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/682432","article-title":"Heart rate recovery is an important predictor of outcomes in patients with connective tissue disease-associated pulmonary hypertension","volume":"5","author":"OA Minai","year":"2015","journal-title":"Pulm Circ"},{"key":"pone.0268839.ref009","first-page":"48","article-title":"Heart rate recovery in response to disease targeted therapy in pre-capillary pulmonary hypertension","author":"A Mackenzie","year":"2016","journal-title":"Eur Respir J"},{"issue":"4","key":"pone.0268839.ref010","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ahj.2012.01.023","article-title":"Heart rate recovery in pulmonary arterial hypertension: relationship with exercise capacity and prognosis","volume":"163","author":"RP Ramos","year":"2012","journal-title":"Am Heart J"},{"issue":"8","key":"pone.0268839.ref011","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.healun.2017.04.008","article-title":"Incremental shuttle walk test distance and autonomic dysfunction predict survival in pulmonary arterial hypertension","volume":"36","author":"CG Billings","year":"2017","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"pone.0268839.ref012","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/S0735-1097(01)01652-7","article-title":"Heart rate recovery: validation and methodologic issues","volume":"38","author":"K Shetler","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"9317","key":"pone.0268839.ref013","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(02)08525-2","article-title":"Abnormal heart rate recovery after exercise","volume":"359","author":"RJ Gibbons","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"pone.0268839.ref014","first-page":"576","article-title":"Six-minute walk test: reference values for healthy adults in Brazil","volume":"37","author":"MR Soares","year":"2011","journal-title":"J Bras Pneumol"},{"key":"pone.0268839.ref015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-0-387-77244-8_17","volume-title":"Clinical prediction models: a practical approach to development, validation, and updating. Statistics for Biology and Health","author":"EW Steyerberg","year":"2009"},{"issue":"115","key":"pone.0268839.ref016","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1183\/09059180.00008509","article-title":"Treatment of right heart failure on pulmonary arterial hypertension: is going left a step in the right direction?","volume":"19","author":"R. Naeije","year":"2010","journal-title":"Eur Respir Rev"},{"issue":"9","key":"pone.0268839.ref017","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1161\/CIRCULATIONAHA.117.027451","article-title":"Contribution of impaired parasympathetic activity to right ventricular dysfunction and pulmonary vascular remodeling in pulmonary arterial hypertension","volume":"137","author":"B\u00f3s D da Silva Gon\u00e7alves","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"pone.0268839.ref018","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/crj.13056","article-title":"Value of heart rate recovery in female patients with pulmonary arterial hypertension due to systemic lupus erythematosus","volume":"13","author":"GL Yang","year":"2019","journal-title":"Clin Respir J"},{"issue":"148","key":"pone.0268839.ref019","doi-asserted-by":"crossref","first-page":"170134","DOI":"10.1183\/16000617.0134-2017","article-title":"The role of cardiopulmonary exercise tests in pulmonary arterial hypertension","volume":"27","author":"S Farina","year":"2018","journal-title":"Eur Respir Rev"},{"key":"pone.0268839.ref020","first-page":"3415401","article-title":"The correlation of decreased heart rate recovery and chronotropic incompetence with exercise capacity in idiopathic pulmonary arterial hypertension patients","volume":"2017","author":"C Wu","year":"2017","journal-title":"Biomed Res Int"},{"issue":"1","key":"pone.0268839.ref021","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1183\/13993003.00023-2016","article-title":"Pulmonary haemodynamics during recovery from maximum incremental cycling exercise","volume":"48","author":"RK Oliveira","year":"2016","journal-title":"Eur Respir J"},{"issue":"4","key":"pone.0268839.ref022","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"MM Hoeper","year":"2016","journal-title":"Lancet Respir Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0268839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T17:30:31Z","timestamp":1653672631000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0268839"}},"subtitle":[],"editor":[{"given":"Nejka","family":"Potocnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0268839","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,27]]}}}